1) Human urinary kallikrein
人尿激肽原酶
1.
CONCLUSION: Human urinary kallikrein for acute cerebral infarction can transiently down-regulate blood pressure slightly,but its effect on blood pressure can be lowered by suitable reduction of its concentration;at any concentration,it can result in hypotension if used in combination with ACEI.
目的:研究不同浓度人尿激肽原酶治疗急性脑梗死对患者血压的影响。
2) Pro urokinase
人尿激酶原
1.
The Construction and Expression of Human Pro urokinase cDNA Coding Deleted Mutant at 150～156 Amino Acids;
人尿激酶原cDNA序列缺失突变体的构建及表达
3) human urinary kallikrein (hKN)
人尿激肽释放酶
1.
The human urinary kallikrein (hKN)and human urinary trypsin inhibitor (hUTI) were two acidic pro-teins in the urine.
人尿激肽释放酶和人尿胰蛋白酶抑制剂是存在于尿中的酸性蛋白。
4) recombinant human prourokinase
重组人尿激酶原
1.
A new thrombolytic drug:recombinant human prourokinase;
新型溶栓药物重组人尿激酶原
2.
Objective:To study the stability of lyophilized recombinant human prourokinase(rhPro-UK).
目的:探讨重组人尿激酶原(rhPro-UK)冻干产品的稳定性。
5) Recombinant human pro-urokinase
重组人尿激酶原
1.
Study of long term toxicity of recombinant human pro-urokinase in rhesus monkeys;
重组人尿激酶原对恒河猴的长期毒性研究
6) scu PA cDNA
人尿激酶原cDNA
补充资料：肾性葡萄糖尿氨基酸尿磷酸盐尿症
肾性葡萄糖尿氨基酸尿磷酸盐尿症
renal glucosuria aminoaciduria and phosphaturia
又称“Fanconi综合征”。遗传性或获得性近端肾小管多种功能异常疾病。临床上表现为肾性糖尿、全氨基酸尿、磷酸盐尿、高血氯性代谢性酸中毒、低血钾、多尿及肾小管性蛋白尿等。遗传性Fanconi综合征又可分为成人型及婴儿型两类，后者又称为“de-Toni-Debre-Fanconi综合征”或“Lignac-Fonconi综合征”。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条